Harvest Portfolios Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Harvest Portfolios Group's BMY Position: Q2 2026 in Review
Harvest Portfolios Group increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, buying an estimated $891K and bringing the position to 1,203,684 shares worth $69.4M. The position accounts for 0.98% of the portfolio, ranked #34.
Harvest Portfolios Group first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $72.1M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Harvest Portfolios Group held 1,203,684 shares of Bristol-Myers Squibb worth $69.4M as of Q2 2026.
- Harvest Portfolios Group bought 15,511 Bristol-Myers Squibb shares in Q2 2026, an estimated $891K.
- Bristol-Myers Squibb made up 0.98% of Harvest Portfolios Group's portfolio in Q2 2026, its #34 holding.
- Harvest Portfolios Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- Harvest Portfolios Group's Bristol-Myers Squibb position peaked at $72.1M in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.